Biostage (BSTG) –
-
Form SC 13G/A Harvard Apparatus Regene Filed by: HARVARD BIOSCIENCE INC
-
Form 8-K Harvard Apparatus Regene For: Feb 01
-
Form 4 Harvard Apparatus Regene For: Jan 11 Filed by: He Junli
-
Form 4 Harvard Apparatus Regene For: Dec 27 Filed by: He Junli
-
Form 4 Harvard Apparatus Regene For: Dec 14 Filed by: He Junli
-
Form 4 Harvard Apparatus Regene For: Dec 06 Filed by: He Junli
-
Form S-8 Harvard Apparatus Regene
-
Form 10-Q Harvard Apparatus Regene For: Sep 30
-
Form 4 Harvard Apparatus Regene For: Sep 11 Filed by: He Junli
-
Form 4 Harvard Apparatus Regene For: Aug 28 Filed by: He Junli
-
Form 4 Harvard Apparatus Regene For: Aug 18 Filed by: He Junli
-
Form 4 Harvard Apparatus Regene For: Aug 21 Filed by: Shmerling James E.
-
Approval of an Orphan Disease Application for its lead product, the Cellspan Esophageal Implant by the European Medicines Agency
-
Form 10-Q Harvard Apparatus Regene For: Jun 30
-
Harvard Apparatus Regenerative Technology Reports Second Quarter 2023 Financial Results
-
Harvard Apparatus Regenerative Technology Schedules Conference Call and Webcast for Q2 2023 Results
-
Form 4 Harvard Apparatus Regene For: Jul 26 Filed by: Sanchez Herman
-
Form 4 Harvard Apparatus Regene For: Jul 26 Filed by: Packard Ronald J
-
Form 4 Harvard Apparatus Regene For: Jul 26 Filed by: Li Ting
-
Form 4 Harvard Apparatus Regene For: Jul 26 Filed by: Chen Jing
-
Form 4 Harvard Apparatus Regene For: Jul 26 Filed by: Shmerling James E.
-
Form 4 Harvard Apparatus Regene For: Jul 26 Filed by: GREEN DAVID
-
Form 8-K Harvard Apparatus Regene For: Jul 20
-
Biostage, Inc. Changes Name to Harvard Apparatus Regenerative Technology, Inc. (OTCQB: HRGN)
-
Form 8-K Harvard Apparatus Regene For: Jul 19
-
Biostage Activated Mayo Clinic as The First Site for Clinical Trial in Severe Esophageal Disease
-
Form 8-K/A Biostage, Inc. For: Jul 10
-
Form 4/A Biostage, Inc. For: Apr 10 Filed by: He Junli
-
Biostage to Host Investor Call
-
Form DEFR14A Biostage, Inc.
-
Form DEFA14A Biostage, Inc.
-
Form DEF 14A Biostage, Inc. For: Jun 05
-
Biostage Initiated Study Start-up Activities for Clinical Trial in Severe Esophageal Disease
-
Form 10-Q Biostage, Inc. For: Mar 31
-
Form 4 Biostage, Inc. For: Apr 12 Filed by: Packard Ronald J
-
Form 3 Biostage, Inc. For: Apr 05 Filed by: Packard Ronald J
-
Form D Biostage, Inc.
-
Form 4 Biostage, Inc. For: Apr 10 Filed by: He Junli
-
Form 4 Biostage, Inc. For: Apr 06 Filed by: DST Capital LLC
-
Form 8-K Biostage, Inc. For: Apr 05
-
Biostage Appoints Ron Packard to Board of Directors
-
Form 8-K Biostage, Inc. For: Mar 31
-
Biostage Announces $6 Million Financing to Advance Clinical Trial
-
Form 10-K Biostage, Inc. For: Dec 31
-
Form 8-K Biostage, Inc. For: Mar 14
-
Form 8-K Biostage, Inc. For: Mar 01
-
Form 4 Biostage, Inc. For: Feb 28 Filed by: GREEN DAVID
-
Biostage (BSTG) Announces Chairman and CEO Transition
-
Biostage Announces Chairman and CEO Transition
-
Form SC 13G/A Biostage, Inc. Filed by: Zhang An
Back to BSTG Stock Lookup